Is HTWR a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

342 people get HTWR articles and Market Currents by email alert.

Get email alerts on HTWR »

FOCUS | PRO | RELATED | TRANSCRIPTS | NEWS & PR

Bull Of The Day: Heartware
Zacks Investment Research • Tue, May 21
Heartware Q1 Results: Good News For All LVAD Companies
Robert Honeywill • Fri, May 3
Heartware's Public Offering: Takeover Bid For Sunshine Heart?
Robert Honeywill • Thu, Mar 21 • 3 Comments
HeartWare Is Premium-Priced Growth, But Could Still Go Higher
Stephen Simpson • Thu, Mar 7 • 8 Comments
FDA Decision Grows Near For Heartware
Growth Stock Insider • Wed, Sep 5, 2012
HeartWare to Advance Clinical Trial
Zacks Investment Research • Tue, Sep 7, 2010
Heartware International: One Stock on an Upbeat
Ray Branton • Fri, Jun 4, 2010

HeartWare Is Premium-Priced Growth, But Could Still Go Higher
Stephen Simpson • Thu, Mar 7 • 8 Comments

Weekly Stock Watch, Week Of 8 April 2013
VFC's Stock House • Mon, Apr 8 • 2 Comments
Risky Sunshine Heart Looks Very Interesting
Stephen Simpson • Thu, Feb 21 • 15 Comments
Thoratec And Heartware Vying For Leadership In Implantable Heart Failure Devices
Stock Traders Daily • Wed, Feb 13 • 6 Comments
Sunshine Heart: When Drugs Don't Work And LVADs Are Too Risky
Robert Honeywill • Mon, Jan 14 • 16 Comments
9 High-Growth Healthcare Stocks With Bearish Stock Trends
Kapitall • Wed, Dec 19, 2012 • 4 Comments
10 Companies With Notable Changes In Short Interest
Inflection Point Investing LLC • Mon, Dec 17, 2012
Is Sunshine The Solution To Device Tax Blues?
Logical Assessment • Tue, Dec 11, 2012 • 4 Comments
Sunshine Heart: A Takeover Bid Just A Heartbeat Away?
Biotech Breakthroughs • Thu, Nov 29, 2012 • 18 Comments
M&A Activity In Medical Devices Could See Focus Shift To MRI Interventions
LastFinancier • Tue, Nov 27, 2012
How The Fiscal Cliff Will Impact U.S. Industry
Kyle Spencer • Tue, Nov 13, 2012 • 3 Comments
Analyst Scott Power Finds The Upside In Biotech Down Under
Life Sciences Report • Thu, Nov 8, 2012
Heart Failure: 'New Epidemic' Creates New Opportunities For Investors
Cris Frangold • Sun, Nov 4, 2012 • 2 Comments
The $5 Billion Opportunity For Sunshine Heart's C-Pulse Device
Adam Sans • Fri, Nov 2, 2012 • 2 Comments
Not Enough Cash For Sunshine Heart
Alberto Savrieno • Tue, Oct 16, 2012 • 15 Comments
FDA Gives The 'OK' In Biggest News For This Medical Device Company To Date
LastFinancier • Mon, Oct 1, 2012 • 23 Comments
6 Highly-Liquid Small-Cap Stocks Headed For Growth
ZetaKap • Wed, Sep 19, 2012
5 Small Cap Stocks Projected For Big Growth And Rated Buy Or Better By Analysts
ZetaKap • Thu, Aug 23, 2012 • 1 Comment
5 Stocks Insiders Are Selling
Insider Monkey • Mon, Jul 23, 2012 • 2 Comments
5 High-Growth Healthcare Small Caps Armed With Cash
ZetaKap • Mon, Jul 2, 2012 • 1 Comment
5 Takeover Targets In The Cardiovascular Medical Device Space
Vatalyst • Mon, Dec 12, 2011 • 1 Comment

HeartWare International Management Presents at Goldman Sachs Healthcare Conference (Transcript)
Wed, Jun 12
HeartWare International's CEO Presents at UBS Global Healthcare Conference Transcript
Mon, May 20
Heartware International's CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)
Thu, May 16
HeartWare International, Inc. CEO Discusses Q1 2013 Results - Earnings Call Transcript
Tue, Apr 30 • 1 Comment
HeartWare International's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Wed, Feb 27 • 1 Comment
HeartWare International, Inc. Q1 2010 Earnings Call Transcript
Mon, May 3, 2010

HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial

PR Newswire (Mon, 8:50AM)
HeartWare Presentation at the Wells Fargo Securities 2013 Healthcare Conference to be Webcast

PR Newswire (Thu, 9:00AM)
HeartWare International Announces Intention To Delist From Australian Securities Exchange (ASX)

PR Newswire (Wed, 8:00AM)
HeartWare Presentation At The Goldman Sachs 34th Annual Global Healthcare Conference To Be Webcast

PR Newswire (Jun 4, 2013)
HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast

PR Newswire (May 16, 2013)
HeartWare Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference to be Webcast

PR Newswire (May 10, 2013)
HeartWare International Reports $49.2 Million In First Quarter 2013 Revenue; 87% Increase From First Quarter Of 2012

PR Newswire (Apr 29, 2013)
HeartWare Schedules First Quarter Conference Call And Webcast

PR Newswire (Apr 15, 2013)
HeartWare International, Inc. Announces Closing of Public Offering of Common Stock

PR Newswire (Mar 18, 2013)
After-Hours Buzz: MW, VRA, ETFC & More

at CNBC.com (Mar 13, 2013)
HeartWare International, Inc. Announces Pricing of Public Offering of Common Stock

PR Newswire (Mar 12, 2013)
HeartWare International, Inc. Announces Public Offering of Common Stock

PR Newswire (Mar 11, 2013)
HeartWare Presentation at the Barclays Capital 2013 Global Healthcare Conference To Be Webcast

PR Newswire (Mar 6, 2013)
HeartWare Presentation At Raymond James 34th Annual Institutional Investors Conference To Be Webcast

PR Newswire (Feb 28, 2013)
HeartWare International Reports Fourth Quarter 2012 Revenue Of $32.7 Million; Full Year 2012 Revenue Of $110.9 Million

PR Newswire (Feb 27, 2013)
HeartWare Schedules Fourth Quarter Conference Call and Webcast

PR Newswire (Feb 19, 2013)
HeartWare Presentation at Leerink Swann Global Healthcare Conference to be Webcast

PR Newswire (Feb 8, 2013)
HeartWare International Announces Preliminary Fourth Quarter 2012 Revenues

PR Newswire (Jan 7, 2013)
HeartWare Presentation At The 31st Annual J.P. Morgan Healthcare Conference To Be Webcast

PR Newswire (Jan 3, 2013)
HeartWare Presentation at the Oppenheimer 23rd Annual Healthcare Conference to be Webcast

PR Newswire (Dec 6, 2012)

HTWR vs. ETF Alternatives

Company Description

"HeartWare is a medical device company focused on developing the world’s smallest implantable blood pumps for the treatment of advanced heart failure.
The HeartWare Ventricular Assist System (the “HeartWare System”), which includes a left ventricular assist device (“LVAD”), or blood pump,... More

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, April 30, 9:10 AM Premarket gainers: HPY +10%. HTWR +9%. ANAD +9%. AVP +8%. UBS +7%. BBY +6%.
Losers: DCTH -20%. AVEO -16%. NUAN -15%. PBI -10%. MTG -8%. CNH -6%. RVBD -6%. QGEN -5%. Comment! [On the Move]
Monday, April 29, 6:19 PM More on HeartWare International (HTWR): Q1 beats across the board on an 87% jump in total sales. Net losses narrowed on U.S. sales of its implantable heart pumps. The company sold a record 482 HVAD pumps globally in the latest period, up from 298 units in Q112 and surpassing its previous high quarterly total of 345 in Q412. Gross margin widened to 61.9% from 58.9%. Shares +7.7% AH. Comment! [Healthcare, Earnings, On the Move]
Monday, April 29, 6:16 PM HeartWare (HTWR): Q1 EPS of -$0.87 beats by $0.34. Revenue of $49.2M beats by $9.52M. (PR) Comment! [Earnings, Breaking News]
Monday, April 29, 6:13 PM HeartWare International (HTWR): Q1 EPS loss of $0.87 beats by $0.33. Revenue of $49.2M (+87% Y/Y) beats by $9.2M. (PR) Shares +7% AH. Comment! [Healthcare, Earnings, On the Move, Breaking News]
Monday, April 29, 5:38 PM After-hours top gainers, as of 5:15 p.m.: HTWR +9%. TXRH +8%. MGT +3%. USLV +3%. BWLD +2%.
After-hours top losers: MCO -8%. RVBD -7%. NSPR -7%. MBI -6%. BAH -3%. 1 Comment [On the Move]
Tuesday, March 12, 3:15 PM HeartWare International (HTWR -2%) trades lower today after the maker of surgically implanted pumps announced plans to sell 1.5M shares. The company plans to use the new funds for working capital and general corporate purposes, including research and development and expanding its manufacturing facilities. Comment! [Healthcare, On the Move]
Wednesday, February 27, 7:37 AM HeartWare International Inc (HTWR): Q4 EPS of -$1.46. Revenue of $32.7M (+42% Y/Y). (PR) Comment! [Earnings, Breaking News, Healthcare]
Wednesday, November 21, 2012, 12:28 PM Thoratec (THOR +5.3%) trades higher today after Wells Fargo ups the shares to Outperform and raises its valuation by roughly 20%. The move comes a day after the FDA approved rival HeartWare International's (HTWR -5.4%) heart-pumping device, and Wells notes that THOR's competing product showed a lower incidence of stroke in recent trials. Comment! [Healthcare, On the Move]
Tuesday, November 20, 2012, 3:13 PM HeartWare (HTWR +7.5%) soars after the company's implantable heart pump receives FDA approval. (PR) Comment! [Healthcare, On the Move]
Thursday, April 26, 2012, 9:25 AM HeartWare's (HTWR) +15.5% premarket on news the company's implantable pump for heart-transplant candidates wins the backing of an FDA advisory panel. If HTWR's Ventricular Assist System also is approved for patients who aren’t eligible for a transplant, the company could split the U.S. market with Thoratec’s (THOR) HeartMate device by 2015, analysts say. Comment! [Healthcare, On the Move]
Thursday, April 26, 2012, 9:20 AM Premarket gainers: PATK +26%. HTWR +15%. REGN +14%. NUAN +14%. LOGI +14%. VHC +12%. CTXS +12%. NRGY +10%. EQIX +9%. CRUS +8%. SPPI +8%. INCY +7%. XLNX +7%. WPI +7%. AMRN +5%. EA +7%. MWW +5%. AH +6%. PHM +6%. AIS +5%. AIXG +5%. LSI +4%. TS +3%. UN +3%. ZNGA +3%. FRO +3%. RDS +3%.
Losers: FURX -28%. PCS -15%. HRB -15%. TQNT -14%. ALU -13%. TSPT -12%. AET -9%. PTX -7%. AKAM -6%. AZN -6%. ZMH -5%. DB -5%. HERO -5%. STD -5%. DOW -4%. CELG -4%. CS -4%. CROX -4%. GG -3%. BWA -3%. UNH -3%. LVS -3%. VALE -3%. UPS -3%. POT -3%. Comment! [On the Move]
Monday, April 23, 2012, 10:09 AM HeartWare (HTWR +5.5%) beating strongly after the FDA says the firm's blood pump appears to aid patients with severe heart failure. However, the agency raises safety concerns about clotting rates and stroke, and says the clinical trials may have missing data and are difficult to compare. An FDA advisory panel is due to vote on the device on Wednesday. Comment! [Healthcare, On the Move]
Thursday, March 29, 2012, 7:32 PM HeartWare International (HTWR) acquires World Heart (WHRT), a developer of of left ventricular assist heart devices, for $8M in an all stock transaction. WHRT +3.7% AH. 1 Comment [Healthcare, M&A]
Friday, March 16, 2012, 11:32 AM Heartware (HTWR -0.3%) gets approval from the FDA to enroll 54 patients in a clinical trial of its "bridge" to a heart transplantation for patients with heart failure. The FDA Circulatory System Devices Panel is slated to review the firm's application to move forward with its ventricular assist system on April 25. Comment! [Healthcare]
Tuesday, February 14, 2012, 12:42 PM HeartWare (HTWR +1.9%) moves higher after an FDA panel says it will review the Premarket Approval application for the company's Ventricular Assist System on April 25. Leerink Swann says the overhang in the shares has been removed following the news, and it believes a Q3 approval and launch is likely. Comment! [Healthcare, On the Move]
Thursday, January 5, 2012, 3:51 PM Thoratec (THOR -3.8%) trades down after UBS cut the shares to Neutral from Buy on valuation. The firm says the stock may be played out over the near term, as peer competitor Heartware's (HTWR +1%) pending launch of HVAD is expected to cut into its heart therapy market share. Comment! [Healthcare, On the Move]

HTWR Heartware International, Inc.

HTWR

Heartware International, Inc.